New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
12:00 EDTBDSIBioDelivery Sciences price target raised to $13 from $9 at Ladenburg
Ladenburg raised its price target on shares of BioDelivery Sciences to $13 from $9 following positive top-line data for one of its BEMA buprenorphine Phase III trials. Ladenburg believes these results portend a high probability for positive results from another ongoing Phase 3 study of the drug in another set of patients and the firm maintains a Buy rating on shares.
News For BDSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
17:12 EDTBDSIBroadfin Capital reports 7.33% passive stake in BioDelivery Sciences
May 14, 2015
19:02 EDTBDSIOn The Fly: After Hours Movers
Subscribe for More Information
16:11 EDTBDSIEndo, BioDelivery announces Phase 3 data for buprenorphine
Subscribe for More Information
May 12, 2015
07:00 EDTBDSIBioDelivery Sciences price target lowered to $12 from $17 at Cantor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use